期刊文献+

Smad4的表达与结直肠癌肝转移的关系 被引量:4

The correlation between the expression of Smad4 and liver metastasis of colorectal carcinoma
暂未订购
导出
摘要 目的探讨Smad4的表达与结直肠癌肝转移的关系。方法通过免疫组化方法检测79例结直肠癌组织和20例癌旁正常组织中Smad4蛋白的表达,选择性别、肿瘤部位、肿瘤大小、肿瘤分化程度、淋巴结转移、大体分型、术前血清CEA水平和Smad4蛋白表达等8个可能影响肝转移的因素,用χ2检验和logistic回归对肝转移的影响因素进行单因素和多因素分析。结果 Smad4蛋白在结直肠癌组织中表达减少,阴性表达率为72.2%(57/79),在结直肠正常组织中阴性表达率为5.0%(1/20),差异有统计学意义(P<0.01)。单因素分析显示,肿瘤分化程度、淋巴结转移、术前血清CEA和Smad4蛋白表达与肝转移有关(P<0.05);多因素分析显示,淋巴结转移、术前血清CEA水平和Smad4蛋白表达与肝转移相关,是结直肠癌肝转移的独立影响因素(OR值分别为6.062、3.725、0.170,均P<0.05)。结论 Smad4蛋白的表达缺失与结直肠癌肝转移明显相关,可作为一个新的预测结直肠癌肝转移的生物指标。淋巴结转移、术前血清CEA水平和Smad4蛋白表达是结直肠癌肝转移的独立影响因素。 Objective To investigate the correlation between the expression of Smad4 and liver metastasis ot colorectal carcinoma. Methods The expression of Smad4 in 79 colorectal carcinoma samples and 20 normal coloreetal samples were assessed by SP immunohistochemistry. Sex, localization of tumor, tumor size, differentiation grade, lymph node metastasis, gross tumor type, preoperative serum CEA, expression of Smad4 were enrolled for Z2 test and logistic regression analysis. Results The negative expression of Smad4 in colorectal carcinoma tissue was 72. 2% ( 57/79 ), while 5.0% (1/20) in normal colorectal tissue, with significant difference between them (P 〈 0.01 ). Differentiation grade, lymph node metastasis, preoperative serum CEA and expression of Smad4 were significantly correlated with liver metastasis according to single factor analysts ( P 〈0.05). However, only lympk Bode metastasis, preoperative serum CEA and expression of Smad4 were significantly correlated with liver metastasis according to muhifactor analysis ( OR = 6. 062, 3.725, and 0. 170 ; P 〈 0.05). Conclusion The down - regulation of Smad4 is correlated with liver metastasis of coloreetal carcinoma, providing a novel biomarker to predict liver metastasis of eolorectal carcinoma. Lymph node metastasis, preoperative serum CEA and expression of Smad4 are independent risk factors of liver metastasis of colorectal carcinoma.
出处 《广东医学》 CAS CSCD 北大核心 2013年第8期1182-1185,共4页 Guangdong Medical Journal
关键词 结直肠癌 免疫组织化学 肝转移 SMAD4 colorectal cancer immunohistochemistry liver metastasis Smad4
  • 相关文献

参考文献1

二级参考文献108

  • 1Hagedorn HG, Bachmeier BE, Nerlich AG. Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-beta in invasive carcinomas. Int J Oncol 2001; 18:669-681.
  • 2Dickson MC, Martin JS, Cousins FM, Kulkami AB, Karlsson S, Akhurst RJ. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 1995; 121:1845-1854.
  • 3Larsson J, Goumans M J, Sjostrand L J, et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type Ⅰ receptor-deficient mice. EMBO J 2001; 20:1663-1673.
  • 4Oshima M, Oshima H, Taketo MM. TGF-beta receptor type Ⅱ deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 1996; 179:297-302.
  • 5Steams ME, Garcia FU, Fudge K, Rhim J, Wang M. Role of interleukin 10 and transforming growth factor betal in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined irnmunodeficiency mice. Clin Cancer Res 1999: 5:711-720.
  • 6Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442-454.
  • 7Derynck R, Akhurst RJ. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 2007; 9:1000-1004.
  • 8Miettinen P J, Ebner R, Lopez AR, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal ceils: involvement of type Ⅰ receptors. J Cell Biol 1994; 127:2021-2036.
  • 9Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGF-betal and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996; 10:2462-2477.
  • 10Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. Regulation of the polarity protein Par6 by TGF- beta receptors controls epithelial cell plasticity. Science 2005; 307:1603-1609.

共引文献57

同被引文献37

  • 1徐铭,刘炳亚.染色体不稳定性与肿瘤[J].医学分子生物学杂志,2006,3(6):430-433. 被引量:1
  • 2Miyaki M, Kuroki T. Role of Smad4 (DPC4) inactivation in hu- man cancer[ J]. Biochem Biophys Res Commun, 2003, 306 (4) : 799 - 804.
  • 3Zhou Z, Lu J, Dou J, et al. FHL1 and Smad4 synergistically in- hibit vascular endothelial growth factor expression [ J ]. Mol Med Rep, 2013, 7(2) : 649 -653.
  • 4L6pez - G6mez M, Moreno - Rubio J, Suirez - Garcia I, et al. Smad4 and TS expression might predict the risk of recurrence after resection of coloreetal liver metastases [ J ]. Clin Transl Oncol, 2015, 17(2) : 133 - 138.
  • 5Malik HZ, Prasad R, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases[ J]. Ann Surg, 2007, 246 : 806 - 814.
  • 6Mejia A, Schulz S, Hyslop T, et al. Molecular staging individuali- zing cancer management[J]. Surg Oncol, 2012, 105(5): 468 - 474.
  • 7Poparic I, Schreibmayer W, Schoser B, et al. Four and a half LIM protein 1C ( FHL1 C) : a binding partner for voltage - gated potassium channel K(vl. 5) [J]. PLoS One, 2011, 6(10): e26524.
  • 8Kamato D, Bureh ML, Piva TJ, et al. Transforming growth factor - 13signalling: role and consequences of Smad linker region phospho- rylation[ J]. Cell Signal, 2013, 25 (10) : 2017 - 2024.
  • 9Handra LA, Olschwang S, Flejou JF. Smad4 protein expression and cell proliferation in eolorectal adenocarcinomas [ J ]. Virehows Arch, 2011,459(5) : 511 -519.
  • 10Li X, Lin B, Xiao J, et al. Roles of VEGF - C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer[ J]. J Gastrointest Surg, 2011 , 15 ( 11 ) : 2001 - 2010.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部